Rolf Stahel
Fortune : 31 297 $ au 31/07/2026
Fortune : 31 297 $ au 31/07/2026
Rolf Stahel is the founder and the Executive Chairman of Chesyl Pharma Ltd., which was founded in 1994.
He is also the Non-Executive Chairman of Ampha Ltd., starting in 2016.
Mr. Stahel's former positions include being the Chief Executive Officer of Shire Pharmaceuticals, Inc. from 1994 to 2003, the Non-Executive Chairman of EUSA Pharma, Inc., the Chairman of Cosmo Pharmaceuticals SA from 2006 to 2010, the Non-Executive Chairman of PowderMed Ltd. in 2006, the Non-Executive Chairman of Newron Pharmaceuticals SpA from 2012 to 2013, the Deputy Chairman of Cosmo Holding SpA in 2007, the Non-Executive Chairman of Connexios Life Sciences Pvt Ltd. from 2009 to 2016, the Non-Executive Chairman of Ergomed Plc from 2014 to 2017, the Non-Executive Chairman of Biodexa Pharmaceuticals Plc from 2014 to 2022, and the Director-Group Marketing of Wellcome Plc from 1967 to 1994.
Mr. Stahel's education includes an undergraduate degree from Kantons-schule.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
Hargreave Hale AIM VCT
Hargreave Hale AIM VCT Investment ManagersFinance Functions as a private equity fund 0,02% | 05/06/2026 | 76 000 ( 0,02% ) | 31 297 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
Ampha Ltd.
Ampha Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Président | 01/12/2016 |
| Sociétés | Poste | Fin |
|---|---|---|
Chesyl Pharma Ltd. | Fondateur | 26/08/2024 |
| BIODEXA PHARMACEUTICALS PLC | Président | 20/06/2022 |
| ERGOMED | Président | 01/03/2017 |
Connexios Life Sciences Pvt Ltd.
Connexios Life Sciences Pvt Ltd. Pharmaceuticals: GenericHealth Technology Discovers and develops small molecule therapeutics | Président | 01/01/2016 |
| NEWRON PHARMACEUTICALS S.P.A. | Président | 18/04/2013 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 13 |
|---|---|
EUSA Pharma, Inc.
EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and researches pharmaceutical products | Health Technology |
Cosmo Pharmaceuticals SA
Cosmo Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Operates as a specialty pharmaceutical company | Health Technology |
Wellcome Plc
Wellcome Plc Miscellaneous Commercial ServicesCommercial Services Operates as a charitable foundation for healthcare | Commercial Services |
PowderMed Ltd.
PowderMed Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapeutic products | Health Technology |
Newron Pharmaceuticals SpA
Newron Pharmaceuticals SpA Pharmaceuticals: MajorHealth Technology Develops and sells novel therapies central & peripheral nervous system | Health Technology |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Cosmo Holding SpA
Cosmo Holding SpA Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Chesyl Pharma Ltd. | |
Connexios Life Sciences Pvt Ltd.
Connexios Life Sciences Pvt Ltd. Pharmaceuticals: GenericHealth Technology Discovers and develops small molecule therapeutics | Health Technology |
Kantons-schule
Kantons-schule Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ergomed Plc
Ergomed Plc BiotechnologyHealth Technology Engages in research and development of drugs for oncology & rare diseases | Health Technology |
Biodexa Pharmaceuticals Plc
Biodexa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Designs and manufactures nanomedicines | Health Technology |
Ampha Ltd.
Ampha Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national